The relative risks of breast and ovarian cancer in BRCA1 and BRCA2 carriers, relative to the BCLC risks (Easton et al, 1993; Ford et al, 1998) were all estimated to be less than one. This evidence concerns the gene BRCA1 and ovarian cancer.